{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:53:13Z","timestamp":1792626793187,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12933-018-0679-y","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:46:00Z","timestamp":1522799160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction"],"prefix":"10.1186","volume":"17","author":[{"given":"Olga","family":"Gruzdeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4321-8977","authenticated-orcid":false,"given":"Evgenya","family":"Uchasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Dyleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Borodkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Akbasheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Belik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Karetnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Brel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kokov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliy","family":"Kashtalap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Barbarash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"679_CR1","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/CIRCRESAHA.115.306885","volume":"118","author":"JJ Fuster","year":"2016","unstructured":"Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118:1786\u2013807.","journal-title":"Circ Res."},{"key":"679_CR2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tips.2017.03.001","volume":"38","author":"Y Ma","year":"2017","unstructured":"Ma Y, Iyer RP, Jung M, Czubryt MP, Lindsey ML. Cardiac fibroblast activation post-myocardial infarction: current knowledge gaps. Trends Pharmacol Sci. 2017;38:448\u201358.","journal-title":"Trends Pharmacol Sci"},{"key":"679_CR3","first-page":"20","volume":"13","author":"Y Wu","year":"2017","unstructured":"Wu Y, Zhang A, Hamilton DJ, Deng T. Epicardial fat in the maintenance of cardiovascular health methodist debakey. Cardiovasc J. 2017;13:20\u20134.","journal-title":"Cardiovasc J"},{"key":"679_CR4","doi-asserted-by":"crossref","first-page":"15314","DOI":"10.3390\/molecules181215314","volume":"18","author":"MM Ciccone","year":"2013","unstructured":"Ciccone MM, Cortese F, Gesualdo M, Riccardi R, Di Nunzio D, Moncelli M. Novel cardiac bio-marker: ST2: a review. Molecules. 2013;18:15314\u201328.","journal-title":"Molecules"},{"key":"679_CR5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","volume":"36","author":"N Venteclef","year":"2015","unstructured":"Venteclef N, Guglielmi V, Balse E, Gaborit B, Cotillard A, Atassi F, et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 2015;36:795\u2013805.","journal-title":"Eur Heart J"},{"key":"679_CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/cvr\/cvu045","volume":"102","author":"SN Hatem","year":"2014","unstructured":"Hatem SN, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res. 2014;102:205\u201313.","journal-title":"Cardiovasc Res"},{"key":"679_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-5-1","volume":"5","author":"AR Baker","year":"2006","unstructured":"Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.","journal-title":"Cardiovasc Diabetol"},{"key":"679_CR8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.atherosclerosis.2010.10.007","volume":"213","author":"M Konishi","year":"2010","unstructured":"Konishi M, Sugiyama S, Sato Y, Oshima S, Sugamura K, Nozaki T, et al. Pericardial fat inflammation correlates with coronary artery disease. Atherosclerosis. 2010;213:649\u201355.","journal-title":"Atherosclerosis"},{"key":"679_CR9","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.179.4.2551","volume":"179","author":"AA Chackerian","year":"2007","unstructured":"Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol. 2007;179:2551\u20135.","journal-title":"J Immunol"},{"key":"679_CR10","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCHEARTFAILURE.113.000207","volume":"6","author":"GM Felker","year":"2013","unstructured":"Felker GM, Fiuzat M, Thompson V, Shaw LK, Neely ML, Adams KF, et al. Soluble ST2 in ambulatory patients with heart failure association with functional capacity and long-term outcomes. Circ Heart Fail. 2013;6:1172\u20139.","journal-title":"Circ Heart Fail"},{"key":"679_CR11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1189\/jlb.3RU0115-012R","volume":"98","author":"Q Gao","year":"2015","unstructured":"Gao Q, Li Y, Li M. The potential role of IL-33\/ST2 signaling in fibrotic diseases. J Leukoc Biol. 2015;98:15\u201322.","journal-title":"J Leukoc Biol"},{"key":"679_CR12","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","volume":"116","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert J, White HD. Joint ESC\/ACCF\/AHA\/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Circulation. 2007;116:2634\u201353.","journal-title":"Circulation"},{"key":"679_CR13","first-page":"19","volume":"15","author":"L Sjostrom","year":"1991","unstructured":"Sjostrom L. A computed tomography based multicompartment body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue. Int J Obes. 1991;15:19\u201330.","journal-title":"Int J Obes"},{"key":"679_CR14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4093\/dmj.2015.39.5.405","volume":"39","author":"DK Song","year":"2015","unstructured":"Song DK, Hong YS, Lee H, Oh JY, Sung YA, Kim Y. Increased epicardial adipose tissue thickness in type 2 diabetes mellitus and obesity. Diabetes Metab J. 2015;39:405\u201313.","journal-title":"Diabetes Metab J"},{"key":"679_CR15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/oby.2006.178","volume":"14","author":"SG Dubois","year":"2006","unstructured":"Dubois SG, Heilbronn LK, Smith SR, Albu JB, Kelley DE, Ravussin E, et al. Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity. 2006;14:1543\u201352.","journal-title":"Obesity"},{"key":"679_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00592-012-0436-8","volume":"51","author":"L Nasarre","year":"2014","unstructured":"Nasarre L, Juan-Babot O, Gastelurrutia P, Llucia-Valldeperas A, Badimon L, Bayes-Genis A, et al. Low density lipoprotein receptor-related protein 1 is upregulated in epicardial fat from type 2 diabetes mellitus patients and correlates with glucose and triglyceride plasma levels. Acta Diabetol. 2014;51:23\u201330.","journal-title":"Acta Diabetol"},{"key":"679_CR17","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/HJH.0000000000000149","volume":"32","author":"E Mart\u00ednez-Mart\u00ednez","year":"2014","unstructured":"Mart\u00ednez-Mart\u00ednez E, Jurado-L\u00f3pez R, Valero-Mu\u00f1oz M, Bartolom\u00e9 MV, Ballesteros S, Luaces M, et al. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity. J Hypertens. 2014;32:1104\u201314.","journal-title":"J Hypertens"},{"key":"679_CR18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MCA.0b013e328351ab2c","volume":"23","author":"Y Xu","year":"2012","unstructured":"Xu Y, Cheng X, Hong K, Huang C, Wan L. How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis. Coron Artery Dis. 2012;23:227\u201333.","journal-title":"Coron Artery Dis"},{"key":"679_CR19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/03014460.2017.1327617","volume":"44","author":"KV Giudici","year":"2017","unstructured":"Giudici KV, Martini LA. Comparison between body mass index and a body shape index with adiponectin\/leptin ratio and markers of glucose metabolism among adolescents. Ann Hum Biol. 2017;44:489\u201394.","journal-title":"Ann Hum Biol"},{"key":"679_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacc.2009.08.047","volume":"55","author":"RA Weir","year":"2010","unstructured":"Weir RA, Miller AM, Murphy GE, Clements S, Steedman T, Connell JM, et al. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coll Cardiol. 2010;55:243\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"679_CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cyto.2015.08.233","volume":"76","author":"WY Chen","year":"2015","unstructured":"Chen WY, Lee RT. ID: 229: endothelial-derived IL-33 is cardioprotective after myocardial pressure overload. Cytokine. 2015;76:107.","journal-title":"Cytokine"},{"key":"679_CR22","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","volume":"134","author":"D Li","year":"2014","unstructured":"Li D, Guabiraba R, Besnard AG, Komai-Koma M, Jabir MS, Zhang L. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate\u00a0lymphoid cells in mice. J Allergy Clin Immunol. 2014;134:1422\u201332.","journal-title":"J Allergy Clin Immunol"},{"key":"679_CR23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12933-017-0612-9","volume":"16","author":"Q Ji","year":"2017","unstructured":"Ji Q, Zhang J, Du Y, Zhu E, Wang Z, Que B, et al. Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease. Cardiovasc Diabetol. 2017;16:133.","journal-title":"Cardiovasc Diabetol"},{"key":"679_CR24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10517-017-3860-5","volume":"163","author":"OV Guzdeva","year":"2017","unstructured":"Guzdeva OV, Akbasheva OE, Dyleva YA, Antonova LV, Matveeva VG, Uchasova EG, et al. Adipokine and cytokine profiles of epicardial and subcutaneous adipose tissue in patients with coronary heart disease. Bull Exp Biol Med. 2017;163:608\u201311.","journal-title":"Bull Exp Biol Med"},{"key":"679_CR25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12933-017-0516-8","volume":"16","author":"R Bouchi","year":"2017","unstructured":"Bouchi R, Terashima M, Sasahara Y, Asakawa M, Fukuda T, Takeuchi T, et al. Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study. Cardiovasc Diabetol. 2017;16:32.","journal-title":"Cardiovasc Diabetol"},{"key":"679_CR26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-017-0658-8","volume":"17","author":"T Sato","year":"2018","unstructured":"Sato T, Aizawa Y, Yuasa S, Kishi S, Fuse K, Fujita S, et al. The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc Diabetol. 2018;17:6.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"679_CR27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cvr\/cvx186","volume":"114","author":"E D\u00edaz-Rodr\u00edguez","year":"2018","unstructured":"D\u00edaz-Rodr\u00edguez E, Agra RM, Fern\u00e1ndez \u00c1L, Adrio B, Garc\u00eda-Caballero T, Gonz\u00e1lez-Juanatey JR, et al. Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability. Cardiovasc Res. 2018;114(2):336\u201346.","journal-title":"Cardiovasc Res"},{"key":"679_CR28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12933-016-0481-7","volume":"15","author":"M Evin","year":"2016","unstructured":"Evin M, Broadhouse KM, Callaghan FM, McGrath RT, Glastras S, Kozor R, et al. Impact of obesity and epicardial fat on early left atrial dysfunction assessed by cardiac MRI strain analysis. Cardiovasc Diabetol. 2016;15:164.","journal-title":"Cardiovasc Diabetol"},{"key":"679_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00380-017-1029-9","volume":"33","author":"MN Kim","year":"2018","unstructured":"Kim MN, Kim HL, Park SM, Shin MS, Yu CW, Kim MA, et al. Association of epicardial adipose tissue with coronary spasm and coronary atherosclerosis in patients with chest pain: analysis of data collated by the KoRean wOmen\u2019S chest pain rEgistry (koROSE). Heart Vessels. 2018;33:17\u201324.","journal-title":"Heart Vessels"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-018-0679-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T01:18:51Z","timestamp":1522977531000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-018-0679-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1186\/s12933-018-0679-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,16]]},"article-number":"40"}}